Eargo, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- William H. Brownie
- Full Time Employees
- 243
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 2665 North First Street San Jose CA United States of America 95134
- IPO Date
- Oct 16, 2020
- CIK
- 0001719395
- Website
- eargo.com
- Similar Companies
- Business
- Eargo, Inc. develops and markets virtually invisible, rechargeable, completely-in-the-canal hearing aids indicated for mild to moderate hearing loss; its core products include the Eargo SE, Link by Eargo earbud-style device with Bluetooth 5.3, Eargo 7, Eargo 6, Eargo 5, Eargo Neo HiFi, Eargo Neo, Eargo Max, and Eargo Plus, featuring Flexi Fiber technology with medical-grade silicone tips, self-fitting adjustments via ear-tap controls, up to 16 hours of battery life, and custom calibration options through licensed hearing professionals. The company sells its devices direct-to-consumer via online platforms, omni-channel retail partnerships, and phone orders, supported by remote consultations, diagnostics, and customer service without in-person visits. Founded in 2010 and headquartered in San Jose, California, Eargo targets U.S. consumers seeking discreet over-the-counter hearing solutions in the medical device and hearing health industry. In March 2025, Eargo completed a merger with hearX Group, maker of Lexie Hearing aids, to form LXE Hearing, a combined over-the-counter hearing aid company backed by $100 million from Patient Square Capital; the entity operates Eargo and Lexie brands under CEO Nic Klopper with Eargo's William Brownie as COO. Patient Square Capital, Eargo's majority owner since 2022, took the company private in January 2024, delisting it from Nasdaq. Earlier, in April 2024, Eargo settled with the U.S. Department of Justice for $34.37 million over alleged improper claims submissions to a federal health program, while denying wrongdoing.
Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients
Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings
EARGO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eargo, Inc. - EAR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Eargo, Inc.
Wolf Popper LLP Investigates the Acquisition of Eargo, Inc. by Its Controlling Shareholder, Patient Square Capital
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm
EARGO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eargo, Inc. - EAR
Eargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and Innovation
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm
Shareholder Alert: Ademi LLP investigates whether Eargo, Inc. has obtained a Fair Price in its transaction with Patient Square Capital
Why Is Eargo (EAR) Stock Up 50% Today?
Eargo Expands Relationship with Best Buy, Growing In-Store Presence to Over 500 Locations
Eargo, Inc. (EAR) Q1 2023 Earnings Call Transcript
Eargo Reports First Quarter 2023 Financial Results
Eargo, Inc. (EAR) Q4 2022 Earnings Call Transcript
Eargo Reports Fourth Quarter 2022 Financial Results
Eargo to Report Fourth Quarter 2022 Financial Results on March 23, 2023